A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of Helicobacter pylori infection

Clinical and Vaccine Immunology

Volumn 20, Issue 11, 2013, Pages 1703-1710

  Formichella, Luca ^a   Romberg, Laura ^a   Bolz, Christian ^a   Vieth, Michael ^c   Geppert, Michael ^b   Göttner, Gereon ^d   Nölting, Christina ^d   Walter, Dirk ^a   Schepp, Wolfgang ^e   Schneider, Arne ^e   Ulm, Kurt ^f   Wolf, Petra ^f   Busch, Dirk H ^a,g   Soutschek, Erwin ^d   Gerhard, Markus ^a,g  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Doctor's Practice for Gastroenterology   (Germany)

^c INSTITUTE OF PATHOLOGY   (Germany)

^d MIKROGEN GMBH   (Germany)

^e KLINIKUM BOGENHAUSEN   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g German Center for Infection Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; CAGA PROTEIN; CHAPERONIN 60; GGT PROTEIN; HCPC PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; UREA PROTEIN; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BLOTTING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOHISTOLOGY; LYSATE BLOTTING; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DIAGNOSTIC TESTS, ROUTINE; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84886738684     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00433-13     Document Type: Article

References (40)

1. Perez-PerezGI, RothenbacherD, BrennerH. 2004. Epidemiology of Helicobacter pylori infection. Helicobacter 9(Suppl. 1):1-6.
2. BlaserMJ, Perez-PerezGI, KleanthousH, CoverTL, PeekRM, ChyouPH, StemmermannGN, NomuraA. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
3. FormanD. 1996. Helicobacter pylori and gastric cancer. Scand. J. Gastroenterol. Suppl. 220:23-26.
4. NomuraA, StemmermannGN, ChyouPH, Perez-PerezGI, BlaserMJ. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med. 120:977-981.
5. ParsonnetJ, FriedmanGD, VandersteenDP, ChangY, VogelmanJH, OrentreichN, SibleyRK. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
6. KustersJG, van VlietAH, KuipersEJ. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449-490.
7. LoganRP, WalkerMM. 2001. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 323:920-922.
8. MalfertheinerP, MegraudF, O'MorainCA, AthertonJ, AxonAT, BazzoliF, GensiniGF, GisbertJP, GrahamDY, RokkasT, El-OmarEM, KuipersEJ. 2012. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut 61:646-664.
9. SelgradM, BornscheinJ, RokkasT, MalfertheinerP. 2010. Clinical aspects of gastric cancer and Helicobacter pylori - screening, prevention, and treatment. Helicobacter 15(Suppl. 1):40-45.
10. ShiotaS, MurakamiK, FujiokaT, YamaokaY. 2010. Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev. Gastroenterol. Hepatol. 4:149-156.
11. ElwynG, TaubertM, DaviesS, BrownG, AllisonM, PhillipsC. 2007. Which test is best for Helicobacter pylori? A cost-effectiveness model using decision analysis. Br. J. Gen. Pract. 57:401-403.
12. CutlerAF, HavstadS, MaCK, BlaserMJ, Perez-PerezGI, SchubertTT. 1995. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 109:136-141.
13. SiddiqueI, Al-MekhaizeemK, AlateeqiN, MemonA, HasanF. 2008. Diagnosis of Helicobacter pylori: improving the sensitivity of CLOtest by increasing the number of gastric antral biopsies. J. Clin. Gastroenterol. 42:356-360.
14. FischbachW, MalfertheinerP, HoffmannJC, BoltenW, BornscheinJ, GotzeO, HohneW, KistM, KoletzkoS, LabenzJ, LayerP, MiehlkeS, MorgnerA, PeitzU, PreissJC, PrinzC, RosienU, SchmidtWE, SchwarzerA, SuerbaumS, TimmerA, TreiberG, ViethM. 2009. S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease". Z. Gastroenterol. 47:68-102. [In German.]
15. CalvetX, LarioS, Ramirez-LazaroMJ, MontserratA, QuesadaM, ReevesL, MastersH, Suarez-LamasD, GallachM, Sanchez-DelgadoJ, Martinez-BauerE, MiquelM, JunqueraF, SanfeliuI, SeguraF. 2010. Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia. Clin. Infect. Dis. 50:323-328.
16. KesliR, GokturkHS, ErbayrakM, KarabagliP, TerziY. 2010. Comparison of the diagnostic values of the 3 different stool antigen tests for the noninvasive diagnosis of Helicobacter pylori infection. J. Investig. Med. 58:982-986.
17. KorkmazH, KesliR, KarabagliP, TerziY. 2013. Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection. Helicobacter 18:384-391.
18. PrellC, OsterriederS, LottspeichC, SchwarzerA, RussmannH, OssianderG, KoletzkoS. 2009. Improved performance of a rapid office-based stool test for detection of Helicobacter pylori in children before and after therapy. J. Clin. Microbiol. 47:3980-3984.
19. BradenB, TeuberG, DietrichCF, CasparyWF, LembckeB. 2000. Comparison of new faecal antigen test with (13)C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. BMJ 320:148.
20. FalaknaziK, JalalzadehM, VafaeimaneshJ. 2010. Noninvasive stool antigen assay for screening of Helicobacter pylori infection and assessing success of eradication therapy in patients on hemodialysis. Iran J. Kidney Dis. 4:317-321.
21. VairaD, HoltonJ, MenegattiM, RicciC, LandiF, AliA, GattaL, AcciardiC, FarinelliS, CrosattiM, BerardiS, MiglioliM. 1999. New immunological assays for the diagnosis of Helicobacter pylori infection. Gut 45(Suppl. 1):I23-I27.
22. BurucoaC, DelchierJC, Courillon-MalletA, de KorwinJD, MegraudF, ZerbibF, RaymondJ, FauchereJL. 2013. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 18:169-179.
23. GaoL, MichelA, WeckMN, ArndtV, PawlitaM, BrennerH. 2009. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res. 69:6164-6170.
24. MiehlkeS, KirschC, Agha-AmiriK, GuntherT, LehnN, MalfertheinerP, StolteM, EhningerG, BayerdorfferE. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87:322-327.
25. WeiGC, ChenJ, LiuAY, ZhangM, LiuXJ, LiuD, XuJ, LiuBR, LingH, WuHX, DuYJ. 2012. Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes and correlation with clinical outcome. Exp. Ther. Med. 4:1039-1044.
26. Murata-KamiyaN. 2011. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect. 13:799-807.
27. ReyndersMB, Miendje DeyiVY, DahmaH, ScheperT, HankeM, DecolvenaerM, DedisteA. 2012. Performance of individual Helicobacter pylori antigens in the immunoblot-based detection of H. pylori infection. FEMS Immunol. Med. Microbiol. 64:352-363.
28. CheyWD, MurthyU, ShawS, ZawadskiA, MontagueJ, LinscheerW, LaineL. 1999. A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial. Am. J. Gastroenterol. 94:1512-1516.
29. RahmanS-HZ. 2008. Non-invasive diagnosis of H pylori infection: evaluation of serological tests with and without current infection marker CIM. World J. Gastroenterol. 14:1231.
30. FusconiM, VairaD, MenegattiM, FarinelliS, FiguraN, HoltonJ, RicciC, CorinaldesiR, MiglioliM. 1999. Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods. Dig Dis. Sci. 44:1691-1695.
31. van DoornLJ, FigueiredoC, SannaR, PlaisierA, SchneebergerP, de BoerW, QuintW. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115:58-66.
32. MontecuccoC, de BernardM. 2003. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 5:715-721.
33. SundrudMS. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. U. S. A. 101:7727-7732.
34. AthertonJC, CaoP, PeekRM, Jr, TummuruMK, BlaserMJ, CoverTL. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.
35. AthertonJC, PeekRM, Jr, ThamKT, CoverTL, BlaserMJ. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99.
36. BauerfeindP, GarnerR, DunnBE, MobleyHL. 1997. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 40:25-30.
37. TorresJ, Camorlinga-PonceM, Perez-PerezG, MunozL, MunozO. 2002. Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin. Diagn. Lab. Immunol. 9:97-100.
38. BoancaG, SandA, BaryckiJJ. 2006. Uncoupling the enzymatic and autoprocessing activities of Helicobacter pylori gamma-glutamyltranspeptidase. J. Biol. Chem. 281:19029-19037.
39. SchmeesC, PrinzC, TreptauT, RadR, HengstL, VolandP, BauerS, BrennerL, SchmidRM, GerhardM. 2007. Inhibition of T-cell proliferation by Helicobacter pylori γ-glutamyl transpeptidase. Gastroenterology 132:1820-1833.
40. StolteM, MeiningA. 2001. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can. J. Gastroenterol. 15:591-598.